1. Seattle Genetics Inc
2. Eli Lilly & Company
3. Johnson & Johnson
4. Novartis AG
5. Pfizer Inc
6. Bristol-Myers Squibb Company
7. Bayer AG
8. AstraZeneca
9. Amgen Inc
Published | Pages | Publisher | Report code |
---|---|---|---|
Nov 2023 | 190 | Renub Research | ASDR-638613 |
1. Seattle Genetics Inc
2. Eli Lilly & Company
3. Johnson & Johnson
4. Novartis AG
5. Pfizer Inc
6. Bristol-Myers Squibb Company
7. Bayer AG
8. AstraZeneca
9. Amgen Inc